Enbrel 50 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DR26FT913
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,618
Award facts
- Contract value 100% obligated
- $20,618.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,618.27 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injector pens on November 14, 2025, with an ultimate completion date of November 17, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Enbrel is a biologic immunosuppressant used primarily to treat rheumatoid arthritis and other autoimmune conditions, making this a specialized pharmaceutical supply for federal healthcare beneficiaries.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion global pharmaceutical supply vehicle that runs through December 2026. As one of the federal government's primary pharmaceutical distributors, AmerisourceBergen Drug Corp supplies a comprehensive range of medications, vaccines, and medical devices to military healthcare systems, the Defense Health Agency, and other federal healthcare customers. The company's inclusion in DLA's strategic procurement initiatives, including the planned Pharmaceutical Prime Vendor Global Program Generation V contracts, underscores its critical role in supporting military medical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26FT913?
SPE2DR26FT913 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26FT913 worth?
The government has obligated $20,618 on SPE2DR26FT913.
Is contract SPE2DR26FT913 an order under another contract?
Yes. SPE2DR26FT913 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FT913 competed?
The extent of competition for SPE2DR26FT913 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award